150 related articles for article (PubMed ID: 7811827)
41. Surgical treatment of papillary and follicular thyroid carcinoma.
Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
[TBL] [Abstract][Full Text] [Related]
42. Comparative studies of nuclear DNA content in benign and malignant thyroid lesions.
Konarska L; Skierski J; Ellert A; Steinbrich J; Woźniak A; Kalczak M
Acta Biochim Pol; 2001; 48(3):783-93. PubMed ID: 11833787
[TBL] [Abstract][Full Text] [Related]
43. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.
Sápi Z; Lukács G; Sztán M; Papp J; Oláh E
Diagn Mol Pathol; 1995 Dec; 4(4):256-60. PubMed ID: 8634781
[TBL] [Abstract][Full Text] [Related]
44. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Cho Mar K; Eimoto T; Tateyama H; Arai Y; Fujiyoshi Y; Hamaguchi M
Histopathology; 2006 Feb; 48(3):286-94. PubMed ID: 16430475
[TBL] [Abstract][Full Text] [Related]
45. Flow-cytometric DNA ploidy analysis in primary and metastatic canine thyroid carcinomas.
Verschueren CP; Rutteman GR; Kuipers-Dijkshoorn NJ; Sjollema BE; Vos JH; van Dijk JE; Cornelisse CJ
Anticancer Res; 1991; 11(5):1755-61. PubMed ID: 1768049
[TBL] [Abstract][Full Text] [Related]
46. Microsatellite instability in thyroid tumours and tumour-like lesions.
Lazzereschi D; Palmirotta R; Ranieri A; Ottini L; Verì MC; Cama A; Cetta F; Nardi F; Colletta G; Mariani-Costantini R
Br J Cancer; 1999 Jan; 79(2):340-5. PubMed ID: 9888478
[TBL] [Abstract][Full Text] [Related]
47. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
[TBL] [Abstract][Full Text] [Related]
48. Correlation between DNA content and p53 deletion in colorectal cancer.
Cianchi F; Balzi M; Becciolini A; Giachè V; Messerini L; Palomba A; Tisti E; Faraoni P; Chellini F; Pucciani F; Perigli G; Cortesini C
Eur J Surg; 1999 Apr; 165(4):363-8. PubMed ID: 10365839
[TBL] [Abstract][Full Text] [Related]
49. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
[TBL] [Abstract][Full Text] [Related]
50. [Investigation on 19 operated cases of intrathoracic thyroid tumors].
Takahashi N; Mawatari T; Kusajima K; Komatsu S
Kyobu Geka; 1996 Oct; 49(11):892-5. PubMed ID: 8913059
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
52. The clinical importance of DNA synthesis and aneuploidy in bone and soft tissue tumours.
Alho A; Skjeldal S; Melvik JE; Pettersen EO; Larsen TE
Anticancer Res; 1993; 13(6B):2383-7. PubMed ID: 8135471
[TBL] [Abstract][Full Text] [Related]
53. Clinical and histological differences in anaplastic thyroid carcinoma.
Rodriguez JM; Piñero A; Ortiz S; Moreno A; Sola J; Soria T; Robles R; Parrilla P
Eur J Surg; 2000 Jan; 166(1):34-8. PubMed ID: 10688214
[TBL] [Abstract][Full Text] [Related]
54. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
55. Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2.
Harach HR; Lesueur F; Amati P; Brown A; Canzian F; Kraimps JL; Levillain P; Menet E; Romeo G; Bonneau D
J Pathol; 1999 Nov; 189(3):387-93. PubMed ID: 10547601
[TBL] [Abstract][Full Text] [Related]
56. DNA content in malignant salivary gland tumours.
Monteiro LS; Palmeira C; Bento MJ; Lopes C
Oral Dis; 2009 May; 15(4):295-301. PubMed ID: 19320959
[TBL] [Abstract][Full Text] [Related]
57. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.
Wallin G; Bäckdahl M; Tallroth-Ekman E; Lundell G; Auer G; Löwhagen T
Eur J Surg Oncol; 1989 Feb; 15(1):43-8. PubMed ID: 2465188
[TBL] [Abstract][Full Text] [Related]
58. DNA aneuploidy in adenomas of endocrine organs.
Joensuu H; Klemi PJ
Am J Pathol; 1988 Jul; 132(1):145-51. PubMed ID: 3394796
[TBL] [Abstract][Full Text] [Related]
59. Follicular neoplasms of the thyroid in men older than 50 years of age. A DNA flow cytometric study.
Hruban RH; Huvos AG; Traganos F; Reuter V; Lieberman PH; Melamed MR
Am J Clin Pathol; 1990 Nov; 94(5):527-32. PubMed ID: 2239819
[TBL] [Abstract][Full Text] [Related]
60. Ag-NOR counting for differentiation of follicular thyroid tumours.
Cör A; Pajer Z
Pathologica; 1994 Jun; 86(3):301-3. PubMed ID: 7808803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
